This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
What will it take to get institutional investors interested in life sciences again?
ABSTRACT: With the European biotechnology market nearing a crisis state, companies must try to attract and maintain interest from institutional investors. In this article, a brief outline of who companies should be trying to appeal to and how these investors view the sector is followed by an assessment of the areas that management must focus on to attract investors...
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
- Management
- Policy
- Finance
- Law
- Regulation
- Bioethics
For more information, see the Journal of Commercial Biotechnology website